SecSonar.com

Assertio Holdings, Inc. (ASRT)

Assertio Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Assertio Holdings, Inc. (ASRT) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $151.4M. Revenue declined 5.0% year-over-year and free cash flow was negative at -$28.2M. This page tracks ASRT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 58 employees · IPO Dec 3, 1997

Valuation

Valuation & price

$23.32 · as of May 17, 2026 · -0.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.61

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$23.50$12.23$0.95Jul 25Dec 25Jun 26Jul 7, 25$0.98Jul 9, 25$1.03Jul 11, 25$1.04Jul 15, 25$0.99Jul 17, 25$1.01Jul 21, 25$1.04Jul 23, 25$1.16Jul 25, 25$1.11Jul 29, 25$1.07Jul 31, 25$1.07Aug 4, 25$1.08Aug 6, 25$1.10Aug 8, 25$1.09Aug 12, 25$1.24Aug 14, 25$1.23Aug 18, 25$1.22Aug 20, 25$1.17Aug 22, 25$1.18Aug 26, 25$1.17Aug 28, 25$1.22Sep 3, 25$1.22Sep 5, 25$1.20Sep 9, 25$1.20Sep 11, 25$1.21Sep 15, 25$1.21Sep 17, 25$1.42Sep 19, 25$1.36Sep 23, 25$1.38Sep 25, 25$1.39Sep 29, 25$1.33Oct 1, 25$1.36Oct 3, 25$1.36Oct 7, 25$1.33Oct 9, 25$1.31Oct 13, 25$1.26Oct 15, 25$1.29Oct 17, 25$1.20Oct 21, 25$1.24Oct 23, 25$1.23Oct 27, 25$1.22Oct 30, 25$1.13Nov 3, 25$1.12Nov 5, 25$1.13Nov 7, 25$1.14Nov 11, 25$1.38Nov 13, 25$1.24Nov 17, 25$1.13Nov 19, 25$1.12Nov 21, 25$1.08Nov 25, 25$1.07Nov 28, 25$1.10Dec 2, 25$1.14Dec 4, 25$1.18Dec 8, 25$1.17Dec 10, 25$1.17Dec 12, 25$1.14Dec 16, 25$1.10Dec 18, 25$1.07Dec 22, 25$1.10Dec 24, 25$0.99Dec 29, 25$0.95Jan 2, 26$9.14Jan 6, 26$9.53Jan 8, 26$9.31Jan 12, 26$9.32Jan 14, 26$1.02Jan 16, 26$1.15Jan 21, 26$1.15Jan 23, 26$1.15Jan 27, 26$1.23Jan 29, 26$1.17Feb 2, 26$1.22Feb 4, 26$1.19Feb 6, 26$1.27Feb 10, 26$1.17Feb 12, 26$1.22Feb 17, 26$1.21Feb 19, 26$1.21Feb 23, 26$1.20Feb 25, 26$1.19Mar 2, 26$1.18Mar 4, 26$1.21Mar 6, 26$1.17Mar 10, 26$1.16Mar 12, 26$1.16Mar 16, 26$1.18Mar 18, 26$1.37Mar 20, 26$1.34Mar 24, 26$1.65Mar 26, 26$1.95Mar 30, 26$1.83Apr 1, 26$1.99Apr 6, 26$1.93Apr 8, 26$1.84Apr 10, 26$1.80Apr 14, 26$1.80Apr 16, 26$1.80Apr 20, 26$1.81Apr 22, 26$1.80Apr 24, 26$1.80Apr 28, 26$1.80May 1, 26$1.85May 5, 26$2.22May 7, 26$2.24May 11, 26$2.24May 13, 26$2.33May 15, 26$2.33May 19, 26$2.34May 21, 26$2.34May 26, 26$2.35May 28, 26$2.34Jun 1, 26$2.34Jun 3, 26$2.35Jun 5, 26$2.34Jun 9, 26$2.35Jun 11, 26$2.35Jun 15, 26$2.35Jun 17, 26$2.35Jun 22, 26$23.50Jun 26, 26$23.50
$0.9552-week range$23.50
Loading valuation history…

Fundamentals

Key fundamentals

$151.4M

Market cap

-5.0%

Revenue growth (YoY)

44.9%

Gross margin

-$28.2M

Free cash flow (USD)

-$24.3M

Net debt

Net cash position

0.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$455.9MFY 2017$380.7MFY 2018$311.8MFY 2019$229.5MFY 2020$108.1MFY 2021$111.0MFY 2022$156.2MFY 2023$152.1MFY 2024$125.0MFY 2025$118.7M
$455.9M$118.7M

Free cash flow by year

2016 → 2025

FY 2016$62.6MFY 2017$61.5MFY 2018$67.0MFY 2019$89.0MFY 2020$-65.6MFY 2021$5.5MFY 2022$78.3MFY 2023$49.0MFY 2024$26.4MFY 2025$-28.2M
$62.6M-$28.2M

Gross margin by year

2021 → 2025

FY 202185.7%FY 202288.0%FY 202382.2%FY 202468.6%FY 202544.9%
85.7%44.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventMerger AgreementJun 16, 2026Filing
  • 8-K eventMerger AgreementMay 18, 2026Filing
  • 8-K eventMerger AgreementMay 13, 2026Filing
  • 8-K eventTender Offer DelayMay 8, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventIncentive Plan AmendedMay 7, 2026Filing
  • 8-K eventTender Offer PostponedMay 5, 2026Filing
  • 8-K eventMerger Agreement AmendedMay 4, 2026Filing
  • 8-K eventTender Offer Deadline ExtendedApr 29, 2026Filing
  • 8-K eventTender Offer AnnouncementApr 21, 2026Filing

Questions

Frequently asked questions

What is Assertio Holdings, Inc.'s market cap?

Assertio Holdings, Inc. (ASRT) has a market capitalization of $151.4M.

What is ASRT's P/E ratio?

A meaningful P/E ratio is not available for ASRT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ASRT's price-to-book (P/B) ratio?

ASRT trades at 1.61 times book value per share.

Are insiders buying ASRT stock?

SEC Form 4 filings show no open-market insider buys at Assertio Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

OGI

Organigram Global Inc.

$163.3M

DERM

Journey Medical Corporation

$171.5M

LFCR

Lifecore Biomedical, Inc.

$187.5M

EMBC

Embecta Corp.

$192.5M

ACB

Aurora Cannabis Inc.

$203.3M

CPIX

Cumberland Pharmaceuticals Inc.

$94.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.